NF1 and glioblastoma: The mesenchymal GBM predominantly harbors loss/mutations in the NF1 tumor suppressor gene coding for neurofibromin 1 and shows TNF family and NFkB pathways activation and expression of mesenchymal markers such as CHI3L1, CD44, and VEGF.